These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33772029)

  • 1. The HSP70-fused foot-and-mouth disease epitope elicits cellular and humoral immunity and drives broad-spectrum protective efficacy.
    Jo H; Kim BY; Park SH; Kim HM; Shin SH; Hwang SY; Kim SM; Kim B; Park JH; Lee MJ
    NPJ Vaccines; 2021 Mar; 6(1):42. PubMed ID: 33772029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mincle and STING-Stimulating Adjuvants Elicit Robust Cellular Immunity and Drive Long-Lasting Memory Responses in a Foot-and-Mouth Disease Vaccine.
    Lee MJ; Jo H; Shin SH; Kim SM; Kim B; Shim HS; Park JH
    Front Immunol; 2019; 10():2509. PubMed ID: 31736952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprinosine as a foot-and-mouth disease vaccine adjuvant elicits robust host defense against viral infection through immunomodulation.
    Kim HW; Ko MK; Shin S; Park SH; Park JH; Kim SM; Lee MJ
    Front Cell Infect Microbiol; 2024; 14():1331779. PubMed ID: 38510965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune Responses.
    Lee MJ; Jo H; Park SH; Ko MK; Kim SM; Kim B; Park JH
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32481687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-galacto-D-mannan-mediated Dectin-2 activation orchestrates potent cellular and humoral immunity as a viral vaccine adjuvant.
    Kim HW; Ko MK; Park SH; Shin S; Kim GS; Kwak DY; Park JH; Kim SM; Lee JS; Lee MJ
    Front Immunol; 2024; 15():1330677. PubMed ID: 38433834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
    De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
    Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
    Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
    Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
    Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
    Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
    J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved immune responses and safety of foot-and-mouth disease vaccine containing immunostimulating components in pigs.
    Choi JH; You SH; Ko MK; Jo HE; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Lee JS; Park JH
    J Vet Sci; 2020 Sep; 21(5):e74. PubMed ID: 33016020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease.
    Shin S; Kim HW; Ko MK; Park SH; Kim SM; Park JH; Lee MJ
    Front Microbiol; 2023; 14():1289065. PubMed ID: 38029108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.
    Lei Y; Shao J; Ma F; Lei C; Chang H; Zhang Y
    Mol Immunol; 2020 May; 121():118-126. PubMed ID: 32199211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice.
    Doosti M; Nassiri M; Nasiri K; Tahmoorespur M; Zibaee S
    Microb Pathog; 2019 Jul; 132():30-37. PubMed ID: 31004723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C3d-fused foot-and-mouth disease vaccine platform overcomes maternally-derived antibody interference by inducing a potent adaptive immunity.
    Lee MJ; Kim HM; Shin S; Jo H; Park SH; Kim SM; Park JH
    NPJ Vaccines; 2022 Jun; 7(1):70. PubMed ID: 35764653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bestatin, A Pluripotent Immunomodulatory Small Molecule, Drives Robust and Long-Lasting Immune Responses as an Adjuvant in Viral Vaccines.
    Kim HW; Ko MK; Park SH; Shin S; Kim SM; Park JH; Lee MJ
    Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine CCL20 plasmid improves protective efficacy of the Montanide ISA™ 206 adjuvanted foot-and-mouth disease vaccine in mice model.
    Jayeshbhai C; Hajam IA; Verma AK; Bhanuprakash V; Kondabattula G; Kishore S
    Vaccine; 2018 Aug; 36(35):5318-5324. PubMed ID: 30054161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential Adjuvanticity of CAvant
    Ahn YH; Chathuranga WAG; Shim YJ; Haluwana DK; Kim EH; Yoon IJ; Lim YT; Shin SH; Jo H; Hwang SY; Kim HM; Lee MJ; Park JH; Yoo SS; Lee JS
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.
    Ramírez-Carvajal L; Diaz-San Segundo F; Ramirez-Medina E; Rodríguez LL; de Los Santos T
    J Virol; 2016 Oct; 90(19):8809-21. PubMed ID: 27466421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.